Barbara Gayle Duncan - Feb 3, 2022 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Barbara Duncan by PoA
Stock symbol
OVID
Transactions as of
Feb 3, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 07:48 PM
Previous filing
Jul 2, 2021
Next filing
Apr 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +15K $0.00 15K Feb 3, 2022 Common Stock 15K $2.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date.